Advanced search
Publication Cover
Leukemia & Lymphoma Volume 37, 2000 - Issue 3-4
Submit an article Journal homepage
44
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Soluble Cytokine Levels Correlate with the Activity and Clinical Stage of Hodgkin's Disease at Diagnosis

Claudia Vener Unita' Malattie Linfoproliferative, Servizio di Ematologia, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore, I.R.C.C.S., Via F. Sforza 35, 20122, Milano, Italy
,
Andrea Guffanti Divisione di Medicina I, Ospedale “Fatebenefratelli e Oftalmico”, Corso di Porta Nuova, 23, 20121, Milano, Italy
,
Mauro Pomati Unita' Malattie Linfoproliferative, Servizio di Ematologia, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore, I.R.C.C.S., Via F. Sforza 35, 20122, Milano, Italy
,
Mariangela Colombi Unita' Malattie Linfoproliferative, Servizio di Ematologia, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore, I.R.C.C.S., Via F. Sforza 35, 20122, Milano, Italy
,
Alessandra Aliettf Unita' Malattie Linfoproliferative, Servizio di Ematologia, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore, I.R.C.C.S., Via F. Sforza 35, 20122, Milano, Italy
,
Maria Luis La targia Unita' Malattie Linfoproliferative, Servizio di Ematologia, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore, I.R.C.C.S., Via F. Sforza 35, 20122, Milano, Italy
,
Fabrizia Bamonti-Catena Unita' Malattie Linfoproliferative, Servizio di Ematologia, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore, I.R.C.C.S., Via F. Sforza 35, 20122, Milano, Italy
&
Luca Baldini Unita' Malattie Linfoproliferative, Servizio di Ematologia, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore, I.R.C.C.S., Via F. Sforza 35, 20122, Milano, ItalyCorrespondence[email protected]
 show all
Pages 333-339 | Accepted 20 Oct 1999, Published online: 01 Jul 2009

References

  • Gruss H-J., Pinto A., Duyster J., Poppema S., Herrmann F. Hodgkin's disease: a tumor with disturbed immuno logical pathways. Immunol Today 1997; 18(4)156–163
  • Nadali G., Tavecchia L., Zanolin E., Bonfante V., Viviani S., Camerini E., Musto P., Di Renzo N., Carotenuto M., Chilosi M., Krampera M., Pizzolo G. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. Blood 1998; 91(8)3011–3016
  • Hasenclever D., Diehl V. A prognostic score for advanced Hodgkin's disease. N Engl J Med 1998; 19: 1506–1514
  • Stein H., Hummel M., Dürkop H., Foss H-D., Herbst H. Biology of Hodgkin's disease. The Lymphomas, G. P. Canellos, T. A. Lister, J. L. Sklar. W.B. Saunders Company, Philadelphia 1998; 287–304
  • Younes A., Consoli U., Snell V., Clodi K., Kliche K-O., Palmer J. L., Gruss H. J., Armitage R., Thomas E. K., Cabanillas F., Andreeff M. CD30 ligand in lymphoma patients with CD30+ tumors. J Clin Oncol 1997; 15(11)3355–3362
  • Younes A., Zhao S., Zhang X., Snell V., Clodi K., Kliche K. O., Thomas E., Cabanillas F., Andreeff M. CD30-ligand and CD40-ligand expression in lymph nodes involved with Hodgkin's Disease. Ann Oncol 1997; 8: S97–S100, (suppl. 2)
  • Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115
  • Diehl V., Bohlen H., Wolf J. CD30: cytokines-receptor, differentiation marker or a target molecule for specific immune response. Ann Oncol 1994; 5: 300
  • Gruss H. J., Ulrich D., Dower S. K., Herrmann F., Brach M. A. Activation of Hodgkin cells via the CD30-R induces autocrine secretion of interleukin-6 engaging the NF-kB transcription factor. Blood 1996; 87(6)2443–2449
  • Falini B., Pileri S., Pizzolo G., Dürkop H., Flenghi L., Stirpe F., Martelli M. F., Stein H. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor-receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85(1)1–14
  • Herbst H., Samol J., Foss H-D., Raff T., Niedobitek G. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J Pathol 1997; 182: 299–306
  • Salles G., Bienvenu J., Bastion Y., Barbier Y., Doche C., Warzocha K., Gutowski M-C., Rieux C., Coiffier B. Elevated circulating levels of TNFα and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol 1996; 93: 352–9
  • Brown R. E., Shah N. R., Lobel J. S., George B. A., Gaylord H., Simonich W. L. Interleukin-6-Associated laboratory parameters and immunohistochemistry in symptomatic stage A and B nodular sclerosing Hodgkin's disease in children. Ann Clin Lab Science 1997; 27(1)26–33
  • Seymour J. F., Talpaz M., Hagemeister F. B., Cabanillas F., Kurzrock R. Clinical correlates of elevated serum levels of interleukin-6 in patients with untreated Hodgkin's disease. Excerpta Medica-Am J Med 1997; 102: 21–28
  • Kurzrock R., Redman J., Cabanillas F., Jones D., Rothberg J., Talpaz M. Serum interleukin-6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res 1993; 53: 2118–2124
  • Durkop H., Foss H-D., Demel G., Klotzbach H., Hahn C., Stein H. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells. Blood 1999; 93(2)617–623
  • Herbst H., Foss H-D., Samol J., Araujo I., Klotzbach H., Krause H., Agathanggelou A., Niedobitek G., Stein H. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin disease. Blood 1996; 87(7)2918–2929
  • Sarris A. H., Kliche K. O., Pethambaram P., Preti A., Tucker S., Jackow C., Messina O., Pugh W., Hagemeister F. B., McLaughlin P., Rodriguez M. A., Romaguera J., Fritsche H., Witzig T., Duvic M., Andreeff M., Cabanillas F. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Ann Oncol 1999; 10(4)433–440
  • Brice P. Prognostic factors in advanced Hodgkin's disease-Can they guide therapeutic decisions. N Engl J Med 1998; 339(21)1547–1549

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.